1. Home
  2. DNTH vs KN Comparison

DNTH vs KN Comparison

Compare DNTH & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$53.87

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Knowles Corporation

KN

Knowles Corporation

HOLD

Current Price

$27.95

Market Cap

2.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNTH
KN
Founded
2015
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
DNTH
KN
Price
$53.87
$27.95
Analyst Decision
Strong Buy
Buy
Analyst Count
10
3
Target Price
$71.22
$22.33
AVG Volume (30 Days)
698.2K
711.1K
Earning Date
04-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
69.82
118.94
EPS
N/A
0.50
Revenue
$6,235,000.00
$593,200,000.00
Revenue This Year
N/A
$9.40
Revenue Next Year
N/A
$6.98
P/E Ratio
N/A
$56.96
Revenue Growth
120.63
7.17
52 Week Low
$13.37
$12.19
52 Week High
$57.50
$28.72

Technical Indicators

Market Signals
Indicator
DNTH
KN
Relative Strength Index (RSI) 60.72 66.44
Support Level $33.94 $23.81
Resistance Level $57.50 N/A
Average True Range (ATR) 3.08 0.89
MACD 0.12 0.06
Stochastic Oscillator 92.21 74.85

Price Performance

Historical Comparison
DNTH
KN

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

Share on Social Networks: